Before considering any type of treatment for Sciatica, disc herniation, degenerative disc disease or any other painful condition affecting the spine, it is important to get all your questions answered. Vertebral Axial Decompression, or Vax-D, is a popular new treatment for these conditions that has proven to be very advantageous because it's relatively inexpensive and does not involve surgery. Luckily, there are many resources to have all your Vax-D questions answered before moving forward with treatment.

One of the most extensive collections of data on Vax-D comes from a study that collected statistics from 22 medical centers in the nation where patients have received the therapy. All of these patients were suffering from low back pain that was sometimes accompanied by acute leg pain as well. The study only included patients who had received at least 10 sessions of Vertebral Axial Decompression and were suffering from herniated discs, degenerative discs or facet syndrome prior to the treatment. This was confirmed by diagnostic imaging to ensure the accuracy of the study and the reliability of the data collected. This study serves as a great source of answers for Vax-D questions from prospective patients.

During the course of this study, patients were asked to provide their own quantitative assessments of their pain, mobility and ability to carry out everyday activities. Vertebral Axial Decompression was successful in 71 percent of the 778 cases in the study, with success being defined by a reduction in pain to zero or one on a scale of zero to five. While the patients who described the treatment as successful had a noticeable reduction in pain, they also experienced great improvements in mobility and activities of daily living.

Vax-D is a leading treatment for a number of conditions that cause back pain and neck pain, including Sciatica, disc herniation and degenerative disc disease. There is detailed information available online and from knowledgeable chiropractors and rehabilitation experts for all those considering this treatment.